Back to search

Article

Intersection of Regulatory Analysis and Signature Reversion Uncovers Therapeutic Drugs and Targets for <i>SETBP1</i> -HD

2026-05-26

Abstract excerpt

<h4>Background</h4> SETBP1 haploinsufficiency disorder ( SETBP1 -HD) is a neurodevelopmental condition characterized by developmental delay, speech apraxia, motor deficits, and autism spectrum disorder (ASD), caused by deficiency of the transcription factor (TF) SETBP1. Since current management is limited to symptomatic relief, we defined a robust consensus molecular signature for SETBP1 -HD and prioritized dru...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9f27d397-c1f0-5903-9088-1b8b0102cfed
DOI
10.64898/2026.05.21.726884
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intersection of Regulatory Analysis and Signature Reversion Uncovers Therapeutic Drugs and Targets for <i>SETBP1</i> -HDDOI 10.64898/2026.05.21.726884
Select a neighboring publication to make it the new centre.